Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-02 · accession 0001062993-22-023351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-12-05 | 2022-12-02 | ERNA | HALPERN JOHN D | 10% | P - Purchase | $3.28 | +335.9K | 451.0K | +292% | +$1.10M |
| DI | 2022-12-05 | 2022-12-02 | ERNA | HALPERN JOHN D | 10% | P - Purchase | $0.13 | +671.8K | 671.8K | New | +$87.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | P | A | 335,920 | $3.28 | 450,961 | I As trustee of family trust | — | — | (F3) Each share was purchased as part of a unit consisting of one share and two warrants, for a total purchase price of $3.53 per unit. (F1) Reflects a 1-for-20 reverse stock split effective October 17, 2022. (F4) The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any. |
| 2 | Derivative | Warrants (Right to Purchase) | 2022-12-02 | P | A | 671,840 | $0.13 | 671,840 | I As trustee of family trust | $3.28 · 2023-06-02 to 2028-12-02 | 671,840 Common Stock | (F5) The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation. (F4) The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any. |